Ara - Recovery for all - provide free, confidential and non-judgemental gambling information, advice and counselling for those impacted by gambling harms (both the gambler and any ‘affected others’).
They provide this free service in partnership with Gamcare as part of the National Gambling Treatment Service, and cover the whole of BNSSG. They are the regional provider for the South West of England and the national provider for Wales.
Contact details:
Website: www.recovery4all.co.uk/gambling-help/
Email: aragamblingservice@recovery4all.co.uk
Tel: 0330 1340 286
The South West Gambling Service is launching in September 2023. It will provide free confidential support to people across the region affected by gambling addiction. Support will include cognitive behavioural therapy; group sessions; virtual sessions; and support for families and carers.
The first hub will open in Bristol, before launching across the region by December 2023.
The service is available to residents aged 18 and over. For more information visit their page on the AWP website:
The South West Gambling Service
GamCare is the leading provider of information, advice and support for anyone affected by gambling harms. They operate the National Gambling Helpline, provide treatment for anyone who is harmed by gambling, create awareness about safer gambling and treatment, and encourage an effective approach to safer gambling within the gambling industry.
Contact details
Website: www.gamcare.org.uk
Telephone: 0808 8020 133 (open 24 hrs a day, 7 days a week)
see website for details on live chat and WhatsApp chat functions.
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.